| Title |
PEGylation, increasing specific activity and multiple dosing as strategies to improve the risk-benefit profile of targeted radionuclide therapy with 177Lu-DOTA-bombesin analogues
|
|---|---|
| Published in |
EJNMMI Research, June 2012
|
| DOI | 10.1186/2191-219x-2-24 |
| Pubmed ID | |
| Authors |
Simone Däpp, Cristina Müller, Elisa García Garayoa, Peter Bläuenstein, Veronique Maes, Luc Brans, Dirk A Tourwé, Roger Schibli |
Mendeley readers
The data shown below were compiled from readership statistics for 22 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 22 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 9 | 41% |
| Student > Ph. D. Student | 5 | 23% |
| Student > Master | 3 | 14% |
| Student > Bachelor | 2 | 9% |
| Professor > Associate Professor | 1 | 5% |
| Other | 1 | 5% |
| Unknown | 1 | 5% |
| Readers by discipline | Count | As % |
|---|---|---|
| Chemistry | 9 | 41% |
| Agricultural and Biological Sciences | 3 | 14% |
| Medicine and Dentistry | 3 | 14% |
| Pharmacology, Toxicology and Pharmaceutical Science | 2 | 9% |
| Materials Science | 1 | 5% |
| Other | 0 | 0% |
| Unknown | 4 | 18% |